Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Elif Hindié
Based on 31 articles published since 2009
(Why 31 articles?)
||||
Expertise Level
The expertise of Elif Hindié ranks in the
  • Top 0.26%
  • ... of 264,224 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 31 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Hindié, E   ·   Hindié, Elif
Work Locations
Details
Most likely:    CHU Bordeaux      
2017
  • Nuclear Medicine Department, University Hospital of Bordeaux, F-33076 Bordeaux, France · University Bordeaux, INCIA, UMR 5287, F-33400 Talence, France. · CNRS, INCIA, UMR 5287, F-33400 Talence, France. · Surgical Pathology Unit, Department of BioPathology, Institut Bergonié, F-33076 Bordeaux, France. · INSERM, ACTION U1218, F-33076 Bordeaux, France. · Clinical and Epidemiological Research Unit, Institut Bergonié, F-33076 Bordeaux, France. · Oncogenetics Unit, Department of BioPathology, Institut Bergonié, F-33076 Bordeaux, France; and. · Department of Medical Oncology, Institut Bergonié, F-33076 Bordeaux, France. · Nuclear Medicine Department, University Hospital of Bordeaux, F-33076 Bordeaux, France. · Pubmed 28280221
2016
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France. · University Paris-Diderot, INSERM/CNRS UMR944/7212, Paris, France. · Department of Nuclear Medicine, Bordeaux University Hospital, Bordeaux, France. · Pubmed 27245758
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France · Department of Nuclear Medicine, Centre GF Leclerc, Dijon, France. · Department of Nuclear Medicine, Institut Curie, Paris, France. · Department of Nuclear Medicine, University of Bordeaux, Hôpital Haut-Lévêque CHU, Bordeaux, France; and. · Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. · Pubmed 26834096
  • Department of Nuclear Medicine, Saint-Louis Hospital, 1 avenue Claude Vellefaux, 75475, Paris Cedex 10, France. · University Paris-Diderot, PRES Paris Cité, INSERM/CNRS UMR944/7212, Paris, France. · Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA. · University Paris-Diderot, PRES Paris Cité, INSERM/CNRS UMR944/7212, Paris, France. · Department of Medical Oncology, Breast Diseases Centre, Saint-Louis Hospital, Paris, France. · Department of Nuclear Medicine, Haut-Lévêque Hospital, University of Bordeaux, Bordeaux, France. · Pubmed 26758726
  • Department of Nuclear Medicine, APHP, Saint-Louis Hospital, Paris, France University Paris-Diderot, PRES Paris Cité, INSERM/CNRS UMR944/7212, Paris, France · Department of Biostatistics and Information, APHP, Saint-Louis Hospital, Paris, France. · Department of Medical Oncology, Breast Diseases Center, APHP, Saint-Louis Hospital, Paris, France. · University Paris-Diderot, PRES Paris Cité, INSERM/CNRS UMR944/7212, Paris, France Department of Medical Oncology, Breast Diseases Center, APHP, Saint-Louis Hospital, Paris, France. · Department of Nuclear Medicine, CHU Bordeaux, University of Bordeaux, France. · Department of Nuclear Medicine, APHP, Saint-Louis Hospital, Paris, France. · Department of Pathology, APHP, Saint-Louis Hospital, Paris, France; and. · University Paris-Diderot, PRES Paris Cité, INSERM/CNRS UMR944/7212, Paris, France Molecular Oncology Unit, APHP, Saint-Louis, Paris, France. · Pubmed 26697967
  • Bordeaux University Hospital, Bordeaux, France · Saint-Louis Hospital, Paris, France. · Pubmed 27217462
2015
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France. · Department of Nuclear Medicine, Bordeaux University Hospital, Bordeaux, France. · Pubmed 26239284
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France. · INSERM, UMR 1101 LaTIM, CHRU Morvan, 2 avenue Foch, 29609, Brest, France. · DACTIM, Department of Nuclear Medicine, Milétrie Hospital, Poitiers, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France. · Department of Pathology, Saint-Louis Hospital, Paris, France. · Department of Nuclear Medicine, CHU Bordeaux, University of Bordeaux, Bordeaux, France. · INSERM, UMR 1101 LaTIM, CHRU Morvan, 2 avenue Foch, 29609, Brest, France. · Pubmed 26140849
  • From the Department of Nuclear Medicine (D.G., A.M., P.M.), Department of Statistical Sciences (A.S., M.R.R.), Department of Biochemistry (P.d.C.), Breast Diseases Unit and Department of Medical Oncology (S.G., M.E.), and Department of Pathology (A.d.R.), Saint-Louis Hospital, 1 avenue Claude Vellefaux, 75475 Paris Cedex 10, France · INSERM, UMR 1101 LaTIM, Brest, France (M.M., D.V., M.H.) · Department of Nuclear Medicine, CHU Bordeaux, University of Bordeaux, Bordeaux, France (E.H.) · and B2T, Doctoral School, IUH, University of Paris VII, Paris, France (D.G., P.M.). · Pubmed 25915099
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France · Department of Statistical Sciences, Saint-Louis Hospital, Paris, France. · INSERM, UMR 1101 LaTIM, Brest, France. · Department of Biochemistry, Saint-Louis Hospital, Paris, France. · Breast Diseases Unit, Department of Medical Oncology, Saint-Louis Hospital, Paris, France. · Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France. · Department of Pathology, Saint-Louis Hospital, Paris, France. · Department of Nuclear Medicine, CHU Bordeaux, University of Bordeaux, Bordeaux, France. · Pubmed 25883123
  • Department of Nuclear Medicine, Bordeaux University Hospital, Pessac 33604, France. Electronic address: · Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France. · Pubmed 25706465
2014
  • CHU de Bordeaux, Service de Médecine Nucléaire, Bordeaux, France University of Bordeaux, INCIA, UMR 5287, Talence, France CNRS, INCIA, UMR 5287, Talence, France · University of Bordeaux, INCIA, UMR 5287, Talence, France CNRS, INCIA, UMR 5287, Talence, France Division of Cyclotron and Radiopharmaceutical Sciences, Institute of Nuclear Medicine and Allied Sciences, DRDO, New Delhi, India; and. · Division of Cyclotron and Radiopharmaceutical Sciences, Institute of Nuclear Medicine and Allied Sciences, DRDO, New Delhi, India; and. · CHU de Bordeaux, Service de Médecine Nucléaire, Bordeaux, France University of Bordeaux, INCIA, UMR 5287, Talence, France EPHE, Bordeaux, France. · CHU de Bordeaux, Service de Médecine Nucléaire, Bordeaux, France University of Bordeaux, INCIA, UMR 5287, Talence, France CNRS, INCIA, UMR 5287, Talence, France. · Pubmed 25189338
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France; Doctoral School of Biology and Biotechnology, University Institute of Hematology, University of Paris VII, Paris, France. Electronic address: · Department of Nuclear Medicine, Haut-Lévêque Hospital, CHU Bordeaux, University Bordeaux-Segalen, Bordeaux, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France; Centre for Therapeutic Innovation, Saint-Louis Hospital, Paris, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France. · Department of Nuclear Medicine, Santa Maria della Misericordia, Rovigo Hospital, Rovigo, Italy. · Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France; Doctoral School of Biology and Biotechnology, University Institute of Hematology, University of Paris VII, Paris, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France; INSERM U728, University Institute of Hematology, University of Paris VII, Paris, France. · Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France. · Pubmed 24985086
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France; B2T, Doctoral School, IUH, University of Paris VII, France. Electronic address: · Department of Nuclear Medicine, CHU Bordeaux, University of Bordeaux, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France; Department of Biostatistics, Institut Curie, Paris, France. · Department of Biostatistics, Institut Curie, Paris, France. · Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France; B2T, Doctoral School, IUH, University of Paris VII, France. · Department of Pathology, Saint-Louis Hospital, Paris, France. · Department of Biochemistry, Saint-Louis Hospital, Paris, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France; Centre for Therapeutic Innovation, Saint Louis Hospital, Paris, France. · INSERM, UMR 1101 LaTIM, Brest, France. · Pubmed 24841218
2014
  • From the *Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France; †Nuclear Medicine Service, PET Unit, Santa Maria della Misericordia, Rovigo Hospital, Rovigo, Italy; ‡Department of Nuclear Medicine, Haut-Lévêque Hospital, CHU Bordeaux, University Bordeaux-Segalen, Bordeaux, France; and §B2T, Doctoral School, IUH, University of Paris VII, France. · Pubmed 23797233
Probable:    Centre National de la Recherche Scientifique      
2017
  • Nuclear Medicine Department, University Hospital of Bordeaux, F-33076 Bordeaux, France · University Bordeaux, INCIA, UMR 5287, F-33400 Talence, France. · CNRS, INCIA, UMR 5287, F-33400 Talence, France. · Surgical Pathology Unit, Department of BioPathology, Institut Bergonié, F-33076 Bordeaux, France. · INSERM, ACTION U1218, F-33076 Bordeaux, France. · Clinical and Epidemiological Research Unit, Institut Bergonié, F-33076 Bordeaux, France. · Oncogenetics Unit, Department of BioPathology, Institut Bergonié, F-33076 Bordeaux, France; and. · Department of Medical Oncology, Institut Bergonié, F-33076 Bordeaux, France. · Nuclear Medicine Department, University Hospital of Bordeaux, F-33076 Bordeaux, France. · Pubmed 28280221
2014
  • CHU de Bordeaux, Service de Médecine Nucléaire, Bordeaux, France University of Bordeaux, INCIA, UMR 5287, Talence, France CNRS, INCIA, UMR 5287, Talence, France · University of Bordeaux, INCIA, UMR 5287, Talence, France CNRS, INCIA, UMR 5287, Talence, France Division of Cyclotron and Radiopharmaceutical Sciences, Institute of Nuclear Medicine and Allied Sciences, DRDO, New Delhi, India; and. · Division of Cyclotron and Radiopharmaceutical Sciences, Institute of Nuclear Medicine and Allied Sciences, DRDO, New Delhi, India; and. · CHU de Bordeaux, Service de Médecine Nucléaire, Bordeaux, France University of Bordeaux, INCIA, UMR 5287, Talence, France EPHE, Bordeaux, France. · CHU de Bordeaux, Service de Médecine Nucléaire, Bordeaux, France University of Bordeaux, INCIA, UMR 5287, Talence, France CNRS, INCIA, UMR 5287, Talence, France. · Pubmed 25189338
Probable:    Miscellaneous institutions in Bordeaux      
2017
  • Nuclear Medicine Department, University Hospital of Bordeaux, F-33076 Bordeaux, France · University Bordeaux, INCIA, UMR 5287, F-33400 Talence, France. · CNRS, INCIA, UMR 5287, F-33400 Talence, France. · Surgical Pathology Unit, Department of BioPathology, Institut Bergonié, F-33076 Bordeaux, France. · INSERM, ACTION U1218, F-33076 Bordeaux, France. · Clinical and Epidemiological Research Unit, Institut Bergonié, F-33076 Bordeaux, France. · Oncogenetics Unit, Department of BioPathology, Institut Bergonié, F-33076 Bordeaux, France; and. · Department of Medical Oncology, Institut Bergonié, F-33076 Bordeaux, France. · Nuclear Medicine Department, University Hospital of Bordeaux, F-33076 Bordeaux, France. · Pubmed 28280221
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 31 total) written by Elif Hindié about Breast Neoplasms:

  • Expression of Gastrin-Releasing Peptide Receptor in Breast Cancer and Its Association with Pathologic, Biologic, and Clinical Parameters: A Study of 1,432 Primary Tumors. 2017
  • Is (18)FDG uptake useful to decide on chemotherapy in ER+/HER2- breast cancer? 2016
  • ¹⁸F-FDG PET/CT for Staging and Restaging of Breast Cancer. 2016
  • ¹⁸F-FDG PET/CT in the early prediction of pathological response in aggressive subtypes of breast cancer: review of the literature and recommendations for use in clinical trials. 2016
  • ¹⁸F-FDG PET/CT for the Early Evaluation of Response to Neoadjuvant Treatment in Triple-Negative Breast Cancer: Influence of the Chemotherapy Regimen. 2016
  • Internal Mammary Node Irradiation in Breast Cancer: The Issue of Patient Selection. 2016
  • Concerning pretreatment ¹⁸F-FDG PET/CT imaging in patients with large or locally advanced breast cancer. 2015
  • Do clinical, histological or immunohistochemical primary tumour characteristics translate into different (18)F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer? 2015
  • Early Metabolic Response to Neoadjuvant Treatment: FDG PET/CT Criteria according to Breast Cancer Subtype. 2015
  • Baseline Tumor 18F-FDG Uptake and Modifications After 2 Cycles of Neoadjuvant Chemotherapy Are Prognostic of Outcome in ER+/HER2- Breast Cancer. 2015
Show List of Full Article Records
Google Searches

Learn more about Elif Hindié using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
CHU Bordeaux
Centre National de la Recherche Scientifique
Miscellaneous institutions in Bordeaux
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
CHU Bordeaux
2017
  • Nuclear Medicine Department, University Hospital of Bordeaux, F-33076 Bordeaux, France · University Bordeaux, INCIA, UMR 5287, F-33400 Talence, France. · CNRS, INCIA, UMR 5287, F-33400 Talence, France. · Surgical Pathology Unit, Department of BioPathology, Institut Bergonié, F-33076 Bordeaux, France. · INSERM, ACTION U1218, F-33076 Bordeaux, France. · Clinical and Epidemiological Research Unit, Institut Bergonié, F-33076 Bordeaux, France. · Oncogenetics Unit, Department of BioPathology, Institut Bergonié, F-33076 Bordeaux, France; and. · Department of Medical Oncology, Institut Bergonié, F-33076 Bordeaux, France. · Nuclear Medicine Department, University Hospital of Bordeaux, F-33076 Bordeaux, France. · Pubmed 28280221
2016
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France. · University Paris-Diderot, INSERM/CNRS UMR944/7212, Paris, France. · Department of Nuclear Medicine, Bordeaux University Hospital, Bordeaux, France. · Pubmed 27245758
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France · Department of Nuclear Medicine, Centre GF Leclerc, Dijon, France. · Department of Nuclear Medicine, Institut Curie, Paris, France. · Department of Nuclear Medicine, University of Bordeaux, Hôpital Haut-Lévêque CHU, Bordeaux, France; and. · Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. · Pubmed 26834096
  • Department of Nuclear Medicine, Saint-Louis Hospital, 1 avenue Claude Vellefaux, 75475, Paris Cedex 10, France. · University Paris-Diderot, PRES Paris Cité, INSERM/CNRS UMR944/7212, Paris, France. · Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA. · University Paris-Diderot, PRES Paris Cité, INSERM/CNRS UMR944/7212, Paris, France. · Department of Medical Oncology, Breast Diseases Centre, Saint-Louis Hospital, Paris, France. · Department of Nuclear Medicine, Haut-Lévêque Hospital, University of Bordeaux, Bordeaux, France. · Pubmed 26758726
  • Department of Nuclear Medicine, APHP, Saint-Louis Hospital, Paris, France University Paris-Diderot, PRES Paris Cité, INSERM/CNRS UMR944/7212, Paris, France · Department of Biostatistics and Information, APHP, Saint-Louis Hospital, Paris, France. · Department of Medical Oncology, Breast Diseases Center, APHP, Saint-Louis Hospital, Paris, France. · University Paris-Diderot, PRES Paris Cité, INSERM/CNRS UMR944/7212, Paris, France Department of Medical Oncology, Breast Diseases Center, APHP, Saint-Louis Hospital, Paris, France. · Department of Nuclear Medicine, CHU Bordeaux, University of Bordeaux, France. · Department of Nuclear Medicine, APHP, Saint-Louis Hospital, Paris, France. · Department of Pathology, APHP, Saint-Louis Hospital, Paris, France; and. · University Paris-Diderot, PRES Paris Cité, INSERM/CNRS UMR944/7212, Paris, France Molecular Oncology Unit, APHP, Saint-Louis, Paris, France. · Pubmed 26697967
  • Bordeaux University Hospital, Bordeaux, France · Saint-Louis Hospital, Paris, France. · Pubmed 27217462
2015
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France. · Department of Nuclear Medicine, Bordeaux University Hospital, Bordeaux, France. · Pubmed 26239284
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France. · INSERM, UMR 1101 LaTIM, CHRU Morvan, 2 avenue Foch, 29609, Brest, France. · DACTIM, Department of Nuclear Medicine, Milétrie Hospital, Poitiers, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France. · Department of Pathology, Saint-Louis Hospital, Paris, France. · Department of Nuclear Medicine, CHU Bordeaux, University of Bordeaux, Bordeaux, France. · INSERM, UMR 1101 LaTIM, CHRU Morvan, 2 avenue Foch, 29609, Brest, France. · Pubmed 26140849
  • From the Department of Nuclear Medicine (D.G., A.M., P.M.), Department of Statistical Sciences (A.S., M.R.R.), Department of Biochemistry (P.d.C.), Breast Diseases Unit and Department of Medical Oncology (S.G., M.E.), and Department of Pathology (A.d.R.), Saint-Louis Hospital, 1 avenue Claude Vellefaux, 75475 Paris Cedex 10, France · INSERM, UMR 1101 LaTIM, Brest, France (M.M., D.V., M.H.) · Department of Nuclear Medicine, CHU Bordeaux, University of Bordeaux, Bordeaux, France (E.H.) · and B2T, Doctoral School, IUH, University of Paris VII, Paris, France (D.G., P.M.). · Pubmed 25915099
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France · Department of Statistical Sciences, Saint-Louis Hospital, Paris, France. · INSERM, UMR 1101 LaTIM, Brest, France. · Department of Biochemistry, Saint-Louis Hospital, Paris, France. · Breast Diseases Unit, Department of Medical Oncology, Saint-Louis Hospital, Paris, France. · Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France. · Department of Pathology, Saint-Louis Hospital, Paris, France. · Department of Nuclear Medicine, CHU Bordeaux, University of Bordeaux, Bordeaux, France. · Pubmed 25883123
  • Department of Nuclear Medicine, Bordeaux University Hospital, Pessac 33604, France. Electronic address: · Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France. · Pubmed 25706465
2014
  • CHU de Bordeaux, Service de Médecine Nucléaire, Bordeaux, France University of Bordeaux, INCIA, UMR 5287, Talence, France CNRS, INCIA, UMR 5287, Talence, France · University of Bordeaux, INCIA, UMR 5287, Talence, France CNRS, INCIA, UMR 5287, Talence, France Division of Cyclotron and Radiopharmaceutical Sciences, Institute of Nuclear Medicine and Allied Sciences, DRDO, New Delhi, India; and. · Division of Cyclotron and Radiopharmaceutical Sciences, Institute of Nuclear Medicine and Allied Sciences, DRDO, New Delhi, India; and. · CHU de Bordeaux, Service de Médecine Nucléaire, Bordeaux, France University of Bordeaux, INCIA, UMR 5287, Talence, France EPHE, Bordeaux, France. · CHU de Bordeaux, Service de Médecine Nucléaire, Bordeaux, France University of Bordeaux, INCIA, UMR 5287, Talence, France CNRS, INCIA, UMR 5287, Talence, France. · Pubmed 25189338
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France; Doctoral School of Biology and Biotechnology, University Institute of Hematology, University of Paris VII, Paris, France. Electronic address: · Department of Nuclear Medicine, Haut-Lévêque Hospital, CHU Bordeaux, University Bordeaux-Segalen, Bordeaux, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France; Centre for Therapeutic Innovation, Saint-Louis Hospital, Paris, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France. · Department of Nuclear Medicine, Santa Maria della Misericordia, Rovigo Hospital, Rovigo, Italy. · Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France; Doctoral School of Biology and Biotechnology, University Institute of Hematology, University of Paris VII, Paris, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France; INSERM U728, University Institute of Hematology, University of Paris VII, Paris, France. · Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France. · Pubmed 24985086
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France; B2T, Doctoral School, IUH, University of Paris VII, France. Electronic address: · Department of Nuclear Medicine, CHU Bordeaux, University of Bordeaux, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France; Department of Biostatistics, Institut Curie, Paris, France. · Department of Biostatistics, Institut Curie, Paris, France. · Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France; B2T, Doctoral School, IUH, University of Paris VII, France. · Department of Pathology, Saint-Louis Hospital, Paris, France. · Department of Biochemistry, Saint-Louis Hospital, Paris, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France; Centre for Therapeutic Innovation, Saint Louis Hospital, Paris, France. · INSERM, UMR 1101 LaTIM, Brest, France. · Pubmed 24841218
2014
  • From the *Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France; †Nuclear Medicine Service, PET Unit, Santa Maria della Misericordia, Rovigo Hospital, Rovigo, Italy; ‡Department of Nuclear Medicine, Haut-Lévêque Hospital, CHU Bordeaux, University Bordeaux-Segalen, Bordeaux, France; and §B2T, Doctoral School, IUH, University of Paris VII, France. · Pubmed 23797233
Centre National de la Recherche Scientifique
2017
  • Nuclear Medicine Department, University Hospital of Bordeaux, F-33076 Bordeaux, France · University Bordeaux, INCIA, UMR 5287, F-33400 Talence, France. · CNRS, INCIA, UMR 5287, F-33400 Talence, France. · Surgical Pathology Unit, Department of BioPathology, Institut Bergonié, F-33076 Bordeaux, France. · INSERM, ACTION U1218, F-33076 Bordeaux, France. · Clinical and Epidemiological Research Unit, Institut Bergonié, F-33076 Bordeaux, France. · Oncogenetics Unit, Department of BioPathology, Institut Bergonié, F-33076 Bordeaux, France; and. · Department of Medical Oncology, Institut Bergonié, F-33076 Bordeaux, France. · Nuclear Medicine Department, University Hospital of Bordeaux, F-33076 Bordeaux, France. · Pubmed 28280221
2014
  • CHU de Bordeaux, Service de Médecine Nucléaire, Bordeaux, France University of Bordeaux, INCIA, UMR 5287, Talence, France CNRS, INCIA, UMR 5287, Talence, France · University of Bordeaux, INCIA, UMR 5287, Talence, France CNRS, INCIA, UMR 5287, Talence, France Division of Cyclotron and Radiopharmaceutical Sciences, Institute of Nuclear Medicine and Allied Sciences, DRDO, New Delhi, India; and. · Division of Cyclotron and Radiopharmaceutical Sciences, Institute of Nuclear Medicine and Allied Sciences, DRDO, New Delhi, India; and. · CHU de Bordeaux, Service de Médecine Nucléaire, Bordeaux, France University of Bordeaux, INCIA, UMR 5287, Talence, France EPHE, Bordeaux, France. · CHU de Bordeaux, Service de Médecine Nucléaire, Bordeaux, France University of Bordeaux, INCIA, UMR 5287, Talence, France CNRS, INCIA, UMR 5287, Talence, France. · Pubmed 25189338
Miscellaneous institutions in Bordeaux
2017
  • Nuclear Medicine Department, University Hospital of Bordeaux, F-33076 Bordeaux, France · University Bordeaux, INCIA, UMR 5287, F-33400 Talence, France. · CNRS, INCIA, UMR 5287, F-33400 Talence, France. · Surgical Pathology Unit, Department of BioPathology, Institut Bergonié, F-33076 Bordeaux, France. · INSERM, ACTION U1218, F-33076 Bordeaux, France. · Clinical and Epidemiological Research Unit, Institut Bergonié, F-33076 Bordeaux, France. · Oncogenetics Unit, Department of BioPathology, Institut Bergonié, F-33076 Bordeaux, France; and. · Department of Medical Oncology, Institut Bergonié, F-33076 Bordeaux, France. · Nuclear Medicine Department, University Hospital of Bordeaux, F-33076 Bordeaux, France. · Pubmed 28280221
Universite de Bordeaux
2016
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France · Department of Nuclear Medicine, Centre GF Leclerc, Dijon, France. · Department of Nuclear Medicine, Institut Curie, Paris, France. · Department of Nuclear Medicine, University of Bordeaux, Hôpital Haut-Lévêque CHU, Bordeaux, France; and. · Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. · Pubmed 26834096
  • Department of Nuclear Medicine, Saint-Louis Hospital, 1 avenue Claude Vellefaux, 75475, Paris Cedex 10, France. · University Paris-Diderot, PRES Paris Cité, INSERM/CNRS UMR944/7212, Paris, France. · Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA. · University Paris-Diderot, PRES Paris Cité, INSERM/CNRS UMR944/7212, Paris, France. · Department of Medical Oncology, Breast Diseases Centre, Saint-Louis Hospital, Paris, France. · Department of Nuclear Medicine, Haut-Lévêque Hospital, University of Bordeaux, Bordeaux, France. · Pubmed 26758726
  • Department of Nuclear Medicine, APHP, Saint-Louis Hospital, Paris, France University Paris-Diderot, PRES Paris Cité, INSERM/CNRS UMR944/7212, Paris, France · Department of Biostatistics and Information, APHP, Saint-Louis Hospital, Paris, France. · Department of Medical Oncology, Breast Diseases Center, APHP, Saint-Louis Hospital, Paris, France. · University Paris-Diderot, PRES Paris Cité, INSERM/CNRS UMR944/7212, Paris, France Department of Medical Oncology, Breast Diseases Center, APHP, Saint-Louis Hospital, Paris, France. · Department of Nuclear Medicine, CHU Bordeaux, University of Bordeaux, France. · Department of Nuclear Medicine, APHP, Saint-Louis Hospital, Paris, France. · Department of Pathology, APHP, Saint-Louis Hospital, Paris, France; and. · University Paris-Diderot, PRES Paris Cité, INSERM/CNRS UMR944/7212, Paris, France Molecular Oncology Unit, APHP, Saint-Louis, Paris, France. · Pubmed 26697967
2015
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France. · INSERM, UMR 1101 LaTIM, CHRU Morvan, 2 avenue Foch, 29609, Brest, France. · DACTIM, Department of Nuclear Medicine, Milétrie Hospital, Poitiers, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France. · Department of Pathology, Saint-Louis Hospital, Paris, France. · Department of Nuclear Medicine, CHU Bordeaux, University of Bordeaux, Bordeaux, France. · INSERM, UMR 1101 LaTIM, CHRU Morvan, 2 avenue Foch, 29609, Brest, France. · Pubmed 26140849
  • From the Department of Nuclear Medicine (D.G., A.M., P.M.), Department of Statistical Sciences (A.S., M.R.R.), Department of Biochemistry (P.d.C.), Breast Diseases Unit and Department of Medical Oncology (S.G., M.E.), and Department of Pathology (A.d.R.), Saint-Louis Hospital, 1 avenue Claude Vellefaux, 75475 Paris Cedex 10, France · INSERM, UMR 1101 LaTIM, Brest, France (M.M., D.V., M.H.) · Department of Nuclear Medicine, CHU Bordeaux, University of Bordeaux, Bordeaux, France (E.H.) · and B2T, Doctoral School, IUH, University of Paris VII, Paris, France (D.G., P.M.). · Pubmed 25915099
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France · Department of Statistical Sciences, Saint-Louis Hospital, Paris, France. · INSERM, UMR 1101 LaTIM, Brest, France. · Department of Biochemistry, Saint-Louis Hospital, Paris, France. · Breast Diseases Unit, Department of Medical Oncology, Saint-Louis Hospital, Paris, France. · Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France. · Department of Pathology, Saint-Louis Hospital, Paris, France. · Department of Nuclear Medicine, CHU Bordeaux, University of Bordeaux, Bordeaux, France. · Pubmed 25883123
2014
  • CHU de Bordeaux, Service de Médecine Nucléaire, Bordeaux, France University of Bordeaux, INCIA, UMR 5287, Talence, France CNRS, INCIA, UMR 5287, Talence, France · University of Bordeaux, INCIA, UMR 5287, Talence, France CNRS, INCIA, UMR 5287, Talence, France Division of Cyclotron and Radiopharmaceutical Sciences, Institute of Nuclear Medicine and Allied Sciences, DRDO, New Delhi, India; and. · Division of Cyclotron and Radiopharmaceutical Sciences, Institute of Nuclear Medicine and Allied Sciences, DRDO, New Delhi, India; and. · CHU de Bordeaux, Service de Médecine Nucléaire, Bordeaux, France University of Bordeaux, INCIA, UMR 5287, Talence, France EPHE, Bordeaux, France. · CHU de Bordeaux, Service de Médecine Nucléaire, Bordeaux, France University of Bordeaux, INCIA, UMR 5287, Talence, France CNRS, INCIA, UMR 5287, Talence, France. · Pubmed 25189338
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France; Doctoral School of Biology and Biotechnology, University Institute of Hematology, University of Paris VII, Paris, France. Electronic address: · Department of Nuclear Medicine, Haut-Lévêque Hospital, CHU Bordeaux, University Bordeaux-Segalen, Bordeaux, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France; Centre for Therapeutic Innovation, Saint-Louis Hospital, Paris, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France. · Department of Nuclear Medicine, Santa Maria della Misericordia, Rovigo Hospital, Rovigo, Italy. · Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France; Doctoral School of Biology and Biotechnology, University Institute of Hematology, University of Paris VII, Paris, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France; INSERM U728, University Institute of Hematology, University of Paris VII, Paris, France. · Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France. · Pubmed 24985086
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France; B2T, Doctoral School, IUH, University of Paris VII, France. Electronic address: · Department of Nuclear Medicine, CHU Bordeaux, University of Bordeaux, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France; Department of Biostatistics, Institut Curie, Paris, France. · Department of Biostatistics, Institut Curie, Paris, France. · Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France; B2T, Doctoral School, IUH, University of Paris VII, France. · Department of Pathology, Saint-Louis Hospital, Paris, France. · Department of Biochemistry, Saint-Louis Hospital, Paris, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France; Centre for Therapeutic Innovation, Saint Louis Hospital, Paris, France. · INSERM, UMR 1101 LaTIM, Brest, France. · Pubmed 24841218
2014
  • From the *Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France; †Nuclear Medicine Service, PET Unit, Santa Maria della Misericordia, Rovigo Hospital, Rovigo, Italy; ‡Department of Nuclear Medicine, Haut-Lévêque Hospital, CHU Bordeaux, University Bordeaux-Segalen, Bordeaux, France; and §B2T, Doctoral School, IUH, University of Paris VII, France. · Pubmed 23797233
Miscellaneous cities in France
2015
  • Saint-Louis Hospital 1 Avenue Claude Vellefaux Paris 75475, France E-mail: · Pubmed 26045310
Hopitaux Universitaires Saint-Louis Lariboisiere Fernand-Widal
2012
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris 7 University, Paris, France. · Pubmed 22172908
2011
  • Nuclear Medicine, Saint-Louis Hospital, University of Paris VII, Paris, France. · Pubmed 21321267
2015
  • Department of Nuclear Medicine, Saint-Louis Hospital, 1 avenue Claude Vellefaux, 75475, Paris Cedex 10, France, · Pubmed 25432784
2014
  • From the *Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France; †Nuclear Medicine Service, PET Unit, Santa Maria della Misericordia, Rovigo Hospital, Rovigo, Italy; ‡Department of Nuclear Medicine, Haut-Lévêque Hospital, CHU Bordeaux, University Bordeaux-Segalen, Bordeaux, France; and §B2T, Doctoral School, IUH, University of Paris VII, France. · Pubmed 23797233
2013
  • Department of Nuclear Medicine and Department of Medical Oncology, Breast Diseases Unit, Saint-Louis Hospital, 1 avenue Claude Vellefaux, 75475 Paris Cedex 10, France. · Pubmed 23220901
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France. · Pubmed 23510894
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France. · Pubmed 23213197
  • Nuclear Medicine, Saint-Louis Hospital, 1 avenue Claude Vellefaux, Paris 75475, France. · Pubmed 23942075
2012
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France. · Pubmed 22241914
  • Service de Médecine Nucléaire, Hôpital Saint-Louis, Assistance publique Hôpitaux de Paris, 1 Ave Claude Vellefaux, 75475 Paris Cedex 10, France. · Pubmed 23243198
2011
  • Department of Nuclear Medicine, Saint-Louis Hospital, Assistance publique Hôpitaux de Paris, Paris, France. · Pubmed 21057787
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France. · Pubmed 21880576
Universite Paris 7 Diderot
2012
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris 7 University, Paris, France. · Pubmed 22172908
2011
  • Nuclear Medicine, Saint-Louis Hospital, University of Paris VII, Paris, France. · Pubmed 21321267
2015
  • Department of Nuclear Medicine, Saint-Louis Hospital, 1 avenue Claude Vellefaux, 75475, Paris Cedex 10, France, · Pubmed 25432784
2014
  • From the *Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France; †Nuclear Medicine Service, PET Unit, Santa Maria della Misericordia, Rovigo Hospital, Rovigo, Italy; ‡Department of Nuclear Medicine, Haut-Lévêque Hospital, CHU Bordeaux, University Bordeaux-Segalen, Bordeaux, France; and §B2T, Doctoral School, IUH, University of Paris VII, France. · Pubmed 23797233
2013
  • Department of Nuclear Medicine and Department of Medical Oncology, Breast Diseases Unit, Saint-Louis Hospital, 1 avenue Claude Vellefaux, 75475 Paris Cedex 10, France. · Pubmed 23220901
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France. · Pubmed 23510894
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France. · Pubmed 23213197
  • Nuclear Medicine, Saint-Louis Hospital, 1 avenue Claude Vellefaux, Paris 75475, France. · Pubmed 23942075
2012
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France. · Pubmed 22241914
  • Service de Médecine Nucléaire, Hôpital Saint-Louis, Assistance publique Hôpitaux de Paris, 1 Ave Claude Vellefaux, 75475 Paris Cedex 10, France. · Pubmed 23243198
2011
  • Department of Nuclear Medicine, Saint-Louis Hospital, Assistance publique Hôpitaux de Paris, Paris, France. · Pubmed 21057787
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France. · Pubmed 21880576
4 Other Locations Show
Yearly article counts 00158463400
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.